Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 7793 - 7800 of 12038 results

Data Security Gets New Look With Insurance Tax Credit Bill
September 20, 2016| News

Mass. District Court Holds Private Equity Funds Liable for a Portfolio Entity’s Pension Benefits
September 19, 2016| Alert| Viewpoint

Developers Who Elect Not to Pay Comprehensive Permit Fees in Full Proceed at Their Peril
September 19, 2016| Alert| Viewpoint

New York Proposes First-Ever Cybersecurity Regulation for Financial Institutions
September 19, 2016| Blog| Viewpoint

Law Revamping Medicare ID Cards to Be Revived
September 19, 2016| Blog| Viewpoint

California Joins New York and Florida, Passes Out-Of-Network Legislation
September 19, 2016| Blog| Viewpoint

Proposed Rule Would Bolster Medicaid Fraud Program
September 19, 2016| News

U.S. Offshore Wind Industry Readies for Take-off Led by Northeast U.S.
September 16, 2016| Blog| Viewpoint
News & Press Releases
San Francisco Business Times featured Mintz’s new office lease in San Francisco at 525 Market St. The firm will be increasing its footprint in downtown by 50% to 29,000 square feet on a whole single floor with the new space.
Mintz advised the underwriters in connection with a $230 million public offering by Cogent Biosciences, Inc. of 25,555,556 shares of common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses.
Mintz advised the underwriters in connection with a $200 million public offering by Soleno Therapeutics, Inc. of 2,352,941 shares of its common stock at a price to the public of $85.00 per share. The gross proceeds to Soleno from the offering were approximately $200 million before deducting underwriting discounts and commissions and other offering expenses. In addition, Soleno granted the underwriters a 30-day option to purchase up to an additional 352,941 shares of its common stock at the public offering price.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
